what do glp 1 injections do GLP-1 GLP-1 Agonists: A Comprehensive Overview
Description
In clinical trials, nausea affected roughly 44% of people taking Wegovy and up to 30-40% of tirzepatide users at higher doses
Citing various estimates, PwC pegged the current GLP-1 market at $133 billion, with the potential to climb to $150 billion by 2030
If not, then why is there extra medication in the pen to begin with
What Makes It Different
Diabetes Research and Clinical Practice , 199, 110634
Additionally, they create an optimized solution for data analysis
